![]() Trendlines Group brought seven of its Israel-based portfolio companies (out of 48) on a roadshow in Singapore, the first since Trendlines was listed on the Singapore Exchange last November. ![]() Below are pictures of the CEOs and a brief description of the technologies which reflect Trendlines' stated objective of "helping to improve the human condition".
From Singapore, the Trendlines party will head to Hong Kong, Shenzhen, Shanghai and Beijing to meet investors there. In its roadshows, Trendlines seeks to attract financial investments into its portfolio companies to enable them to develop and commercialise their innovations.
Trendlines' business model is still something new to many Singapore investors -- which is likely why its stock valuation has been trading below its peers'. ![]() DBS Vickers, the only house covering the stock currently, has a 28-cent target price based on FY16F P/BV of 1.1x (versus selected peers trading at 1.3x). Trendlines' Co-Chairman Todd Dollinger says the book value is conservatively estimated, and the real value is substantially higher. "We think that when people understand the potential in these companies, they'll understand the hidden value in our portfolio." ![]() Photo: Company |
NextInsight photosEdit Goldberg, CEO, Escala Medical: Nonsurgical, incision-free approach to treat pelvic organ prolapse
Zvi Peer, CEO, Gordian Surgical: Trocar with integrated closure system
Oren Cohen, CEO,OrthoSpin: Smart external fixation system
Shahar Millis, CEO,Fidmi Medical:Uniquely designed, low-profile enteral feeding device
Omer Zelka, CEO, ElastiMed: Easy-to-wear compression stocking made from smart materials.
Michael Zilbershlag, CEO, Leviticus Cardio: Wireless coplanar energy transfer for ventricular assist devices
Shai Golan, CEO, ProArc Medical:Minimally invasive solution for enlarged prostate